SCHEMBL6134249

SCHEMBL6134249

CC(C)n1nc(-c2sc(C(=O)NCc3ccccn3)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.46
LMNA P02545 6/20 0.45
HTT P42858 3/20 0.45
NAMPT P43490 1/20 0.45
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 10/20 0.43
KDM4E B2RXH2 6/20 0.43
ADORA2A P29274 2/20 0.43
ADORA1 P30542 2/20 0.43
KMT2A Q03164 3/20 0.42
USP2 O75604 2/20 0.42
MEN1 O00255 2/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 3/20 0.42
TP53 P04637 1/20 0.41
MAPK1 P28482 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133345 0.93 SMN1; SMN2 (0.49) TSHRLMNAHTTNAMPTRAB9A
SCHEMBL6133519 0.92 CYP3A4 (0.43) TSHRLMNAHTTNAMPTRAB9A
SCHEMBL6134702 0.91 ADORA2A (0.49) TSHRLMNAHTTNAMPTPOLB
SCHEMBL6134645 0.91 ADORA2A (0.49) TSHRLMNAHTTNAMPTALDH1A1
SCHEMBL6133825 0.89 ADORA2A (0.46) TSHRLMNAHTTALDH1A1KDM4E
SCHEMBL6133161 0.89 L3MBTL1 (0.47) TSHRLMNANPC1POLBALDH1A1
SCHEMBL6133509 0.88 TSHR (0.48) TSHRLMNAHTTNAMPTRAB9A
SCHEMBL6133423 0.87 MMP13 (0.43) TSHRLMNANAMPTALDH1A1HSD17B10
SCHEMBL6133811 0.87 NPC1 (0.40) HTTNPC1POLBALDH1A1KDM4E
SCHEMBL6133417 0.86 KDM4E (0.49) TSHRLMNAHTTNAMPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR TSHR 20/4885LMNA 4780/4885HTT 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.